TITLE

Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery

AUTHOR(S)
Blomquist, S.; Gustafsson, V.; Manolopoulos, T.; Pierre, L.
PUB. DATE
January 2009
SOURCE
Perfusion;Jan2009, Vol. 24 Issue 1, p13
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Endotoxaemia is thought to occur in cardiac surgery using extracorporeal circulation (ECC) and a positive correlation has been proposed between the magnitude of endotoxaemia and risk for postoperative complications. We studied the effects of a new endotoxin adsorber device (Alteco® LPS adsorber) in patients undergoing cardiac surgery with ECC, with special reference to safety and ease of use. Fifteen patients undergoing coronary artery bypass and/or valvular surgery were studied. In 9 patients, the LPS Adsorber was included in the bypass circuit between the arterial filter and the venous reservoir. Flow through the adsorber was started when the aorta was clamped and stopped at the end of perfusion. Flow rate was kept at 150 ml/min. Six patients served as controls with no adsorber in the circuit. Samples were taken for analysis of endotoxin, TNFα, IL-1β and IL-6 as well as complement factors C3, C4 and C1q. Whole blood coagulation status was evaluated using thromboelastograpy (TEG) and platelet count. No adverse events were encountered when the adsorber was used in the circuit. Blood flow through the device was easily monitored and kept at the desired level. Platelet count decreased in both groups during surgery. TEG data revealed a decrease in whole blood clot strength in the control group while it was preserved in the adsorber group. Endotoxin was detected in only 2 patients and IL-1β in 4 patients. IL-6 decreased in both groups whereas no change in TNF concentrations was found. C3 fell in both groups, but no changes wer found in C4 and C1q. The Alteco® LPS adsorber can be used safely and is easy to handle in the bypass circuit. No complications related to the use of the adsorber were noted. The intended effects of the adsorber, i.e. removal of endotoxin from the blood stream could not be evaluated in this study, presumably due to the small number of patients and the relatively short perfusion times.
ACCESSION #
43090933

 

Related Articles

  • The relationship between heparin level and activated clotting time in the adult cardiac surgery population. FitzGerald, D. J.; Patel, A.; Body, S. C.; Garvin, S. // Perfusion;Mar2009, Vol. 24 Issue 2, p93 

    The purpose of this descriptive study was to examine the relationship between heparin levels (HL) determined by heparin protamine titration (HPT) and activated clotting time (ACT) for cardiopulmonary bypass (CPB) in an adult cardiac surgery population. We examined institutional databases for all...

  • Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population. FitzGerald, D. // Perfusion;Mar2009, Vol. 24 Issue 2, p97 

    Information about the issues discussed at the 30th Annual Seminar of the American Academy of Cardiovascular Perfusion held in Dallas, Texas from February 5-8, 2009 is presented. Topics include the relationship of heparin level and activated clotting time in the adult cardiac surgery populace....

  • Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods. Poller, Leon; Keown, Michelle; Chauhan, Nikhil; van den Besselaar, Anton M. H. P.; Tripodi, Armmado; Shiach, Caroline; Jespersen, Jorgen; Greaves, Murray // BMJ: British Medical Journal (International Edition);7/5/2003, Vol. 327 Issue 7405, p30 

    Abstract Objective To find out how accurately two point of care test systems--CoaguChek Mini and TAS PT-NC (RapidPointCoag)--display international normalised ratios (INRs). Design Comparison of the INRs from the two systems with a "true" INR on a conventional manual test from the same sample of...

  • Heparin antibodies, independent of HIT, common in patients undergoing cardiac surgery.  // Formulary;Jan2006, Vol. 41 Issue 1, p46 

    The article reports on the efficacy of heparin antibodies in patients undergoing cardiac surgery. The presence of antibodies to heparin posed risk factor for potentially serious complications following cardiac surgery. This still occurs even in patients who do not develop heparin-induced...

  • Latest Research.  // Medical Economics;11/3/2006, Vol. 83 Issue 21, p16 

    The article presents abstracts of medical research. They include "Post-Anticoagulant D-dimer Level Sign of Recurrent Clot Risk," "Spiral CT Scans Can Detect Lung Cancer While Still Curable," "Rituximab Helps With Refractory Pemphigus Vulgaris," and "Psychopathology Seen in Kids With Intellectual...

  • High risk of bleeding with combination of anti-clotting drugs.  // Nursing Standard;12/6/2006, Vol. 21 Issue 13, p14 

    The article presents a study on the effects of anti-clotting drugs on patients with serious upper gastrointestinal bleeding. These patients were exposed to low-dose aspirin, clopidogrel, dipyridamole, vitamin K antagonists and combination antithrobotic treatment. Also, researchers investigated...

  • Causes and timing of delayed bleeding after oral surgery. Czembirek, Cornelia; Poeschl, Wolfgang; Eder-Czembirek, Christina; Fischer, Michael; Perisanidis, Christos; Jesch, Philip; Schicho, Kurt; Dong, Angel; Seemann, Rudolf // Clinical Oral Investigations;Jul2014, Vol. 18 Issue 6, p1655 

    Objectives: This study examines a cohort of patients who suffered bleeding requiring hemostatic intervention after oral surgery. The reasons for bleeding and the interval between surgery and onset of bleeding are investigated. Materials and methods: Between 1998 and 2009, 1,819 cases were...

  • The effect of heparin on graft thrombosis in pediatric renal allografts. Nagra, Arvind; Trompeter, Richard S.; Fernando, Oswald N.; Koitman, Geoff; Taylor, John O.; Lord, Rozanne; Hutchinson, Carol; O'Sullivan, Caoimhe; Rees, Lesley // Pediatric Nephrology;May2004, Vol. 19 Issue 5, p531 

    Graft thrombosis is an important cause of early (<4 weeks) renal graft loss. Reports show that heparin reduces the incidence of early renal allograft thrombosis. Routine peri-operative administration of unfractionated heparin was introduced in our unit in 1994. We conducted a retrospective study...

  • Preventing Blood Clots after Knee Arthroscopy.  // Annals of Internal Medicine;7/15/2008, Vol. 149 Issue 2, pI40 

    The article focuses on the risks of blood clots in the veins of the legs brought by orthopedic surgical procedures like hip and knee replacements. It states that clots can travel through bloodstream and primarily the cause of blockages of arteries in the lungs. It notes that doctors provide...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics